Sharon Smith

Patients needing interpreters wait longer for evaluation in the emergency department; a study highlights delays in care initiation and potential inequities in treatment. Medscape Medical News source https://www.medscape.com/viewarticle/patients-needing-interpreters-experience-delays-ed-care-2026a10009kn?src=rss

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening. Medscape Medical News source https://www.medscape.com/viewarticle/sleeve-gastrectomy-tied-improved-vascular-markers-2026a10009js?src=rss

A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis. Medscape Medical News source https://www.medscape.com/viewarticle/pcks9s-seen-driving-down-ldl-c-diabetes-2026a10009jb?src=rss

The JAK1 inhibitor in development for treating nonsegmental vitiligo was superior to placebo on investigator ratings in two phase 3 trials. Medscape Medical News source https://www.medscape.com/viewarticle/upadacitinib-results-significant-improvements-nonsegmental-2026a10009j2?src=rss

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments. Medscape Medical News source https://www.medscape.com/viewarticle/dermatomyositis-targeted-drug-shows-promise-vs-placebo-2026a10009iz?src=rss

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative. Medscape Medical News source https://www.medscape.com/viewarticle/champion-af-trial-finds-laac-alternative-noac-lower-risk-2026a10009ij?src=rss